Metabolic Changes Induced by Genetically Modified Potatoes
Status
Unknown
Conditions
Satiety
Glucose Metabolism
Endocrine Metabolism
Treatments
Other: Genetically modified potatoes
Details and patient eligibility
About
Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.
Enrollment
50 estimated patients
Sex
Male
Ages
18 to 60 years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- healthy males
Exclusion criteria
- no acute oder severe chronic diseases
Trial design
Primary purpose
Basic Science
Allocation
Randomized
Interventional model
Single Group Assignment
Masking
Single Blind
50 participants in 7 patient groups
Starch 1
Other group
Description:
Starch 1
Treatment:
Other: Genetically modified potatoes
Starch 2
Other group
Description:
Starch 2
Treatment:
Other: Genetically modified potatoes
Starch 3
Other group
Description:
Starch 3
Treatment:
Other: Genetically modified potatoes
Starch 4
Other group
Description:
Starch 4
Treatment:
Other: Genetically modified potatoes
Starch 5
Other group
Description:
Starch 5
Treatment:
Other: Genetically modified potatoes
Starch 6
Other group
Description:
Starch 6
Treatment:
Other: Genetically modified potatoes
Starch 7
Other group
Description:
Starch 7
Treatment:
Other: Genetically modified potatoes
Trial contacts and locations
1
Loading...
Central trial contact
Joachim Spranger, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems